What’s behind PE’s latest health-kick?

This week’s blog comes from Matt Bartell, EY’s UKI Transaction Advisory Life Sciences Leader and Paddy Moser, co-leader of UKI Transaction Advisory Private Equity.  There’s no doubt that health is one of the biggest stories in private equity right now. In the second quarter, the healthcare sector accounted for almost a quarter of global PE … More What’s behind PE’s latest health-kick?

Is your M&A strategy too safe?

This week’s blog comes from Julie Hood, Global Deputy Vice Chair of Transaction Advisory Services at EY. We’re all wrestling with how to future-proof our businesses. Digitisation and convergence have created bigger sector ecosystems with nimbler predators. The risk of being blindsided by a new technology or start-up has never been greater. Corporate longevity has … More Is your M&A strategy too safe?

What makes data valuable?

This week’s blog comes from Anna Faelten, an Associate Partner in our TAS TMT team Data, data everywhere…but what actually has value? Do you have a hidden gem? The value question is one that I am increasingly being asked as the digital age allows – and indeed encourages – organisations to collect increasing volumes of data … More What makes data valuable?

Time to pay?

This week’s Capital Agenda Blog comes from Matthew Evans, a Partner in EY’s Cash and Working Capital team. The time taken by the UK’s biggest companies to pay their smaller suppliers has been an issue for successive governments, but recent events have pushed it much higher up the political agenda. Major companies’ payment practices are … More Time to pay?